Cannabinoids and dopamine receptors' action on calcium current in rat neurons

Canadian Journal of Neurological Sciences

Volumn 32, Issue 4, 2005, Pages 529-537

  Vásquez, Clemente ^a   Navarro Polanco, R ^a   Hernandez G ^a   Ruiz, J ^a   Guerra, D G ^a   Baltazar, L M ^a   Huerta, M ^a   Trujillo, X ^a  

^a UNIVERSIDAD DE COLIMA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALCOHOL; ANANDAMIDE; CALCIUM ION; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; COMPLEMENTARY DNA; DIHYDREXIDINE; DIMETHYL SULFOXIDE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; METHANANDAMIDE; SODIUM HYDROXIDE; WATER;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CHANNEL GATING; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; MALE; MICROINJECTION; MOLECULAR CLONING; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SYMPATHETIC NERVE CELL;

EID: 29044445143     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S031716710000456X     Document Type: Article

References (51)

1. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346:561-564.
2. Gifford AN, Ashby CR. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J Pharmacol Exp Ther 1996; 277:1431-1436.
3. Katona I, Sperlágh B, Sík A, et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 1999; 19:4544-4558.
4. Hoffman AF, Lupica CR. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci 2000; 20:2470-2479.
5. Kathmann M, Bauer U, Schlicker E, Gothert M. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn-Schmiedeberg's Arch Pharmacol 1999; 359:466-470.
6. Nakazi M, Bauer U, Nickel T, Kathmann M, Schlicker E. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 2000; 361:19-24.
7. Kim DJ, Thayer SA. Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures. Brain Res 2000; 852:398-405.
8. 2+ channels in a neuronal expression system. Mol Pharmacol 1996; 49:707-714.
9. Twitchell W, Brown S, Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 1997; 78:43-50.
10. Mackie K, Lai Y, Westenbroek R, Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 1995; 15:6552-6561.
11. + M-current in hippocampal CA1 neurons. J Neurosci 2000; 20:51-58.
12. Bidaut-Rusell M, Hewlett A. Cannabinoid receptor-regulated cyclic AMP accumulation in the rat striatum. J Neurochem 1991; 57:1769-1773.
13. Glass M, Brotchie JM, Maneuf YP. Modulation of neurotransmission by cannabinoids in the basal ganglia. Eur J Neurosci 1997; 9:199-203.
14. Glass M, Felder CC. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 1997; 17:5327-5333.
15. Rawls SM, Cowan A, Tallarida RJ, Geller EB, Adler MV. N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4- morpholinylmethyl)-1 (1-naphthalenyl-carbonyl)-6H pyrrolo[3,2,1i,j]quinolin-6- one] a cannabinoid agonist, interact to produce synergistic hypothermia. J Pharmacol Exp Ther 2002; 303:395-402.
16. Doherty J, Dingledine R. Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system. Curr Opin Pharmacol 2003; 3:46-53.
17. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 1981; 391:85-100.
18. 2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Mol Pharmacol 1998; 54:1064-1072.
19. Bouaboula M, Perrachon S, Milligan L, et al. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 1997; 272:22330-22339.
20. Landsman RS, Burkey TH, Consroe P, Roeske WR, Yamamura HI. SR 141716A is an inverse agonist at the human cannabinoid CB1 receptor. Eur J Pharmacol 1997; 334: R1-R2.
21. MacLennan SJ, Reynen PH, Kwan J, Bonhaus DW. Evidence for inverse agonism of SR 141716A at human recombinant cannabinoid CB1 and CB2 receptors. Br J Pharmacol 1998; 124:619-622.
22. McAllister SD, Griffin G, Satin LS, Abood ME. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. J Pharmacol Exp Ther 1999; 291:618-626.
23. Bigornia L, Allen CN, Jan CR, et al. D2 dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells. J Pharmacol Exp Ther 1990; 252:586-592.
24. Pfeiffer-Linn C, Lasater EM. Dopamine modulates in a differential fashion T and L-type calcium currents in bass retinal horizontal cells. J Gen Physiol 1993; 102:277-294.
25. Osipenko ON, Varnai O, Mike A, Spät A, Bici E. Dopamine blocks T-type calcium channels in cultured rat adrenal glomerulosa cells. Endocrinology 1994; 134:511-514.
26. Surmeier DJ, Bargas J, Hemmings HC Jr, Nairn AC, Greengard P. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 1995; 14:385-397.
27. 2+ current by the dopamine D1 receptor in rat adrenal glomerulosa cells: requirement of the combined action of the Gβγ protein subunit and cyclic adenosine 3′,5′-monophosphate. Mol Endocrinol 1997; 11:503-514.
28. Ikeda SR, Lovinger DM, McCool BA, Lewis DL. Heterologous expression of metabotropic glutamate receptors in adult rat sympathetic neurons: subtype-specific coupling to ion channels. Neuron 1995; 14:1029-1038.
29. Knoflach F, Woltering T, Adam G, Mutel V, Kemp JA. Pharmacological properties of native metabotropic glutamate receptors in freshly dissociated Golgi cells of the rat cerebellum. Neuropharmacology 2001; 40:163-169.
30. 2+ currents in myenteric neurons. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1282-G1289.
31. Plummer MR, Logothetis DE, Hess P. Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron 1989; 2:1453-1463.
32. Ikeda SR. Double-pulse calcium channel current facilitation in adult rat sympathetic neurons. J Physiol 1991; 439:181-214.
33. Barret CF, Rittenhouse AR. Modulation of N-type calcium channel activity by G-proteins and protein kinase C. J Gen Physiol 2000; 115:277-286.
34. Herkenham M, Lynn AB, Johnson MR, et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991; 11:563-583.
35. Sanudo-Pena MC, Walker JM. Effects of intrapallidal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Synapse 1998; 28:27-32.
36. Sanudo-Pena MC, Patrick SL, Patrick RL, Walker JM. Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Neurosci Lett 1996; 206:21-24.
37. Ferraro L, Tomasini MC, Gessa GL, et al. The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study. Cereb Cortex 2001; 11:728-733.
38. Barbara JG, Auclair N, Roisin MP, et al. Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signaling in layer V pyramidal neurons from the rat prefrontal cortex. Eur J Neurosci 2003; 17:981-990.
39. Pertwee R, Griffin G, Fernando S. AM630, a competitive cannabinoid receptor antagonist. Life Sci 1995; 56:1949-1955.
40. Ross RA, Brockie HC, Stevenson, LA, et al. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 1999; 126:665-672.
41. Costa T, Ogino Y, Munson PJ, Onaran HO, Rodbard D. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol Pharmacol 1992; 41:549-560.
42. Chidiac P, Hebert TE, Valiquette M, Dennis M, Bouvier M. Inverse agonist activity of β-adrenergic antagonists. Mol Pharmacol 1994; 45; 490-499.
43. Samama P, Pei G, Costa T, Cotecchia S, Lefkowitz RJ. Negative antagonists promote an inactive conformation of the β2-adrenergic receptor. Mol Pharmacol 1994; 45:390-394.
44. Zhou X, Galligan JJ. Non-additive interaction between nicotinic cholinergic and P2X purine receptors in guinea-pig enteric neurons in culture. J Physiol 1998; 513:685-697.
45. Schiffmann SN, Lledo P-M, Vincent J-D: Dopamine D1 receptor modulates the voltage gated sodium current in rat striatal neurons through a protein kinase A. J Physiol 1995; 483:95-107.
46. Rodriguez de Fonseca F, Martin Calderon JL, Mechoulam R, Navarro M. Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta8- tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats. Neuroreport 1994; 5:761-765.
47. Jarrahian A, Watts VJ, Barker EL. D2 dopamine receptors modulate Gα-subunit coupling of the CB1 cannabinoid receptor. J Pharmacol Exp Ther 2004; 308:880-886.
48. Sanudo-Pena MC, Force M, Tsou K, Miller AS, Walker JM. Effects of intrastriatal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Synapse 1998; 30:221-226.
49. Giuffrida A, Parsons LH, Kerr TM, et al. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 1999; 2:358-363.
50. 9-tetrahydrocannabinol: dose-response analysis and receptor identification. J Pharmacol Exp Ther 1999; 289:859-867.
51. Fan SF, Yazulla S. Inhibitory interaction of cannabinoid CB1 receptor and dopamine D2 receptor agonists on voltage-gated currents of goldfish cones. Vis Neurosci 2004; 21:69-77.